PDS Biotechnology Corporation (NASDAQ:PDSB) Q2 2025 Earnings Call Transcript August 13, 2025
PDS Biotechnology Corporation beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.24.
Operator: Greetings. Welcome to PDS Biotech Second Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce Mike Moyer with Lifesci Advisors. Thank you. You may begin.
Mike Moyer: Thank you, operator....
